New SEC Form D filing
Way Biosolutions, Inc., 2026-09-25
A new SEC Form D private-offering notice from Cambridge, MA, a $2,000,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Provider of DNA plasmid cloning and gene synthesis services for biotech research labs
Filed 7 days agoFiled to raise $2,000,000First money in 2025-02-14Raised so far $2,000,000HQ (as filed) Cambridge, MASector Biotech web-verified against the company’s own siteStage (inferred) SeedCall status Late filing
Source linked the Form D on EDGAR↗Website verified waybio.us↗Named in the filing 3 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Opus KSD, Inc., 2026-10-01, $681K, Pembroke, MA
- Vertical Longevity Pharmaceuticals, Inc., 2026-09-28, $110K, Irvine, CA
- Tru, Inc., 2026-09-29, $2M, Natick, MA
- Evia Bio, Inc., 2026-09-28, $5.5M, Minneapolis, MN
- Xact Bio, Inc., 2026-09-28, $18M, Boston, MA
- Precision Neuroscience Corp, 2026-09-28, New York, NY
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.